bluebird bio, Inc. - Common Stock (BLUE)

Bluebird Bio is a biotechnology company focused on developing transformative gene therapies for severe genetic disorders and cancer

The company employs innovative genetic modification techniques to address the underlying causes of these diseases, aiming to provide long-lasting and potentially curative solutions for patients. With a commitment to advancing the field of gene therapy, Bluebird Bio is engaged in multiple clinical and preclinical programs that leverage its proprietary technology platform to deliver groundbreaking treatments, paving the way for the future of personalized medicine.